NCT05982717已完成不适用
Epidemiology of Dravet and Lennox-Gastaut Syndromes in Spain
Takeda8 个研究点 分布在 1 个国家目标入组 237 人开始时间: 2023年10月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 237
- 试验地点
- 8
- 主要终点
- Incidence of DS
研究概览
简要总结
The main aims of this study are to gather information about how many children, teenagers and adults in Spain have been diagnosed with Dravet syndrome and Lennox-Gastaut syndrome as well as to learn about the number of new Dravet syndrome and Lennox-Gastaut syndrome cases in persons in Spain.
Participants' data will be taken from their medical records (charts), which were already collected as a part of their routine care in public hospitals in Spain between 01 January 2021 and 31 December 2022.
详细描述
This is a non-interventional, retrospective study of participants from Spain with DS and LGS at public hospitals. The participants will be identified from their medical charts or hospital records and those who meet the eligibility criteria will be included.
This multi-center trial will be conducted in Spain. Data will be retrospectively collected for the observation period between 01 January 2021 to 31 December 2022. The total duration of the study is approximately 24 months.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •A. Diagnosis criteria for DS:
- •All the following criteria must be met: i. Seizures onset within 1-20 months (usually within the first year of life). ii. Normal initial development prior to presentation (no cognitive or behavioural disability before the onset of seizures) followed by behaviour and cognitive impairment.
- •iii. Recurrent focal clonic (hemiclonic) febrile and afebrile seizures (which often alternate sides from seizure to seizure), focal to bilateral tonicclonic, and/or generalized clonic seizures.
- •And at least one of the following criteria must be met: i. Emergence of other seizure type, including atypical absence seizures, myoclonic seizures, atonic seizures, or non-tonic-clonic status epilepticus between 1-4 years.
- •ii. Seizures triggered by fever due to illness or vaccinations, hot baths, sudden temperature changes, high level of activity, or by strong lighting or exposure to certain visual patterns.
- •iii. Mutations or copy number variants in the SCN1A gene.
- •B. Diagnosis criteria for LGS:
- •Given the uncertainties associated with the diagnosis of this condition, two different criteria will be used, a stricter criterion, intended to identify "pure" Lennox-Gastaut syndrome participants, and a wider criterion, intended to also include the so-called Lennox-Gastaut-like participants.
- •Lennox-Gastaut syndrome - stricter criteria:
- •All the following criteria must be met: i. Seizures onset before 18 years of age, typically from 1 to 8 years. ii. Progressive development/cognition impairment after seizures onset. iii. Tonic seizures. iv. At least one additional seizure: generalised tonic-clonic seiures, atypical absence seizures, atonic seizures, myoclonic seizures, focal impaired awareness, epileptic spams, or non-convulsive status epilepticus v. Slow (<2.5 hertz [Hz]) spike-and-wave EEG pattern. vi. Paroxysmal fast activity (10 Hz or greater) in sleep.
- •Lennox-Gastaut syndrome - wider criteria:
- •At least one the following criteria must be met:
- •i. Tonic seizures. ii. Multiple types of seizures, including generalised tonic-clonic seizures, atypical absence seizures, atonic seizures, myoclonic seizures, myoclonic-atonic seizures, focal seizures, epileptic spams, or nonconvulsive status epilepticus.
- •And at least one the following criteria must be met:
- •i. Slow (<2.5 Hz) spike-and-wave EEG pattern. ii. Paroxysmal fast activity (10 Hz or greater) in sleep.
- •And at least two of the following criteria must be met:
- •i. Seizures onset before 18 years of age, typically from 1 to 8 years. ii. Progressive development/cognition impairment after seizures onset. iii. Development/cognition impairment starts prior to seizures onset. iv. History of Infantile epileptic spasms syndrome (IESS), West or Ohtahara syndromes.
排除标准
- •Participants with epileptic condition other than DS or LGS.
- •Participants with DS or LGS not residents in the reference area of the hospital.
结局指标
主要结局
Incidence of DS
时间窗: At two different 12 month periods (in consecutive years at Months 12 and 24)
Number of new participants diagnosed annually with DS yearly.
One-Year Period Prevalence of DS
时间窗: Up to 12 months
Number of participants with DS over a period of one year will be assessed.
One-Year Period Prevalence of LGS Based on Stricter Diagnosis Criterion
时间窗: Up to 12 months
Number of participants with LGS over a period of one year based on stricter diagnosis criterion will be assessed.
Incidence of LGS Based on Stricter Diagnosis Criterion
时间窗: At two different 12 month periods (in consecutive years at Months 12 and 24)
Number of new participants diagnosed annually with LGS based on stricter diagnosis criterion.
次要结局
- One-Year Period Prevalence of Paediatric LGS Based on Stricter and Wider Diagnoses Criteria(Up to 12 months)
- One-Year Period Prevalence of LGS Based on Wider Diagnosis Criterion(Up to 12 months)
- DS Categorized Based on Gender Distribution(Up to 12 months)
- DS Categorized Based on Gender Distribution at Diagnosis(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Incidence of LGS Based on Wider Diagnosis Criterion(At two different 12 month periods (in consecutive years at Months 12 and 24))
- One-Year Period Prevalence of Adult DS(Up to 12 months)
- One-Year Period Prevalence of Adult LGS Based on Stricter and Wider Diagnoses Criteria(Up to 12 months)
- Incidence of Adult DS(At two different 12 month periods (in consecutive years at Months 12 and 24))
- DS Categorized Based on Age Distribution(Up to 12 months)
- LGS Categorized Based on Age Distribution According to Stricter and Wider Diagnoses Criteria(Up to 12 months)
- DS Categorized Based on Gender Distribution at Symptoms Onset(At two different 12 month periods (in consecutive years at Months 12 and 24))
- LGS Categorized Based on Gender Distribution at Diagnosis According to Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Incidence of Paediatric LGS Based on Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Incidence of Adult LGS Based on Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Diagnosis Delay for Participants With LGS Based on Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Participants With DS: Ratio of Participants Genetically (Sodium Channel Protein Type 1 Subunit Alpha [SCN1A] Mutation) and Clinically Diagnosed Versus Participants Clinically Diagnosed Only(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Participants With DS: Number of Participants With Different Types of Comorbidities at Diagnosis(At two different 12 month periods (in consecutive years at Months 12 and 24))
- One-Year Period Prevalence of Paediatric DS(Up to 12 months)
- Incidence of Paediatric DS(At two different 12 month periods (in consecutive years at Months 12 and 24))
- LGS Categorized Based on Gender Distribution According to Stricter and Wider Diagnoses Criteria(Up to 12 months)
- DS Categorized Based on Age Distribution at Diagnosis(At two different 12 month periods (in consecutive years at Months 12 and 24))
- LGS Categorized Based on Age Distribution at Diagnosis According to Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- DS Categorized Based on Age Distribution at Symptoms Onset(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Participants With LGS: Number of Participants Distributed According to Aetiologies Based on Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- LGS Categorized Based on Gender Distribution at Symptoms Onset According to Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- LGS Categorized Based on Age Distribution at Symptoms Onset According to Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Diagnosis Delay for Participants With DS(At two different 12 month periods (in consecutive years at Months 12 and 24))
- Participants With LGS: Number of Participants With Different Types of Comorbidities at Diagnosis Based on Stricter and Wider Diagnoses Criteria(At two different 12 month periods (in consecutive years at Months 12 and 24))
研究者
研究点 (8)
Loading locations...
相似试验
撤回
不适用
A Study on Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in Children, Teenagers and Adults in PortugalDravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)NCT06395792Takeda100
已完成
不适用
Chicago Childhood Diabetes RegistryDiabetes MellitusNCT00204009University of Chicago2,400
已完成
不适用
Epidemiological Study in Children and Adolescents With Chronic Hepatitis BLiver DiseasesHepatitis, ChronicHepatitis, Viral, HumanVirus DiseasesDigestive System DiseasesHepatitis B, ChronicDNA Virus InfectionsHepatitis BHepatitisNCT01163240Novartis Pharmaceuticals1,640
进行中（未招募）
不适用
Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic Kidney Disease (ADPKD)NCT06747572Vertex Pharmaceuticals Incorporated401
Unknown
不适用
COVID-10 in the Pediatric Population: SARS-CoV-2 SeropositivitySARS-CoV-2 InfectionNCT04690114Shaare Zedek Medical Center2,000